At BIO 2026, Thermo Fisher's Anil Kane explains how AI is reshaping CDMO workflows and what biotechs should prioritize when choosing a development partner.
Anil Kane
Advertisement
Articles by Anil Kane
Anil Kane, executive director, Global Head of Formulation Sciences, Pharmaceutical Development Services at Patheon discusses key parameters in the development and manufacturing of oral solid-dosage forms.
Appropriate use of sound science applied at critical junctures will improve efficiency in the high-wire act of drug development.
The author discusses how a CDMO helps in gaining process understanding and in developing robust, high-quality products and processes.
Advertisement
Latest Updated Articles
Quality by Design: A Contract Organization's PerspectiveAugust 1st 2012
Phase-Appropriate Formulation and Process DesignJanuary 2nd 2016
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drapeau’s AI Deep Dive: The Price of Acceptance in Regulated AI
2
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
3
AAPS PharmSci 360: How USP Is Tackling the Novel Excipient Roadblock
4
Why Drug Shortages Average 5+ Years: PharmTech Explained
5